ASCP SH common mistakes
ASCP SH · Understand the traps and how to avoid them.
Calculates the corrected reticulocyte count or reticulocyte production index (RPI) using the patient's hematocrit in the numerator without dividing by the 45% reference hematocrit, or omits the maturation factor entirely, then labels the marrow response as appropriate or inadequate.
The formula is memorized as a fragment under time pressure, and the maturation-factor step is easy to drop because it feels like an extra correction rather than part of the response estimate.
What to do instead
Write the full equation before calculating: corrected reticulocyte % = reticulocyte % × (patient Hct ÷ 45); RPI = corrected reticulocyte % ÷ maturation factor (approximately 1.0 at Hct 45%, 1.5 at 35%, 2.0 at 25%, and 2.5 at 15%). Work two practice cases, one with Hct 25% and one with Hct 40%, and sanity-check that severe anemia should drive the RPI toward 2 or higher before a poor response is called.
Applies adult hemoglobin, MCV, and reticulocyte reference intervals to a neonate, infant, or young child and flags normal physiologic values as pathologic.
Adult reference intervals are overlearned and pediatric hematology is underrepresented in routine review, so age-specific ranges are not retrieved at the moment of interpretation.
What to do instead
Memorize a short age-specific table: newborns have higher Hb (roughly 14–24 g/dL), higher MCV (roughly 100–120 fL), and reticulocytes up to about 5–6%; the physiologic nadir occurs around 8–12 weeks with Hb near 9–11 g/dL; childhood Hb and MCV are lower than adult values. Before flagging a pediatric result, confirm the report is using an age-appropriate interval.
Uses a normal or elevated serum ferritin to exclude iron deficiency in a patient with an inflammatory state, or interprets ferritin without checking CRP or the clinical context.
Ferritin is an acute-phase reactant, and the single cutoff of 'low ferritin equals iron deficiency' is easier to remember than the inflammation-adjusted interpretation.
What to do instead
Interpret ferritin alongside CRP and the CBC: ferritin below 30 ng/mL is strong evidence of iron deficiency, and in inflammation a ferritin up to about 100 ng/mL may still be consistent with iron deficiency. Use transferrin saturation, soluble transferrin receptor, or a therapeutic iron trial when the ferritin is equivocal, and compare with the MCV, RDW, and smear.
Classifies a macrocytic anemia as pure vitamin B12 or folate deficiency without reviewing the RDW, oval macrocytes, hypersegmented neutrophils, or iron studies, missing a mixed deficiency whose MCV averages into the reference range.
The MCV is treated as a definitive classifier, but it is a mean and can be normal when a dimorphic population of microcytes and macrocytes coexists.
What to do instead
Review the RDW and blood smear for dimorphic red cells, oval macrocytes, and hypersegmented neutrophils before committing to a single deficiency. Order B12, folate, methylmalonic acid, homocysteine, ferritin, and iron saturation together when the picture is mixed, and re-evaluate the MCV after treatment rather than assuming one cause.
Diagnoses chronic lymphocytic leukemia from CD5 positivity and CD23 positivity alone without checking CD200, FMC7, surface immunoglobulin intensity, or cyclin D1/SOX11 when morphology or markers are atypical.
A simplified CLL flow panel is easy to memorize, and the overlapping CD5-positive B-cell disorders are hard to distinguish under time pressure.
What to do instead
Use a validated panel: CLL is typically CD5+, CD23+, CD200+, with dim surface immunoglobulin and FMC7 negativity; mantle cell lymphoma is CD5+, usually CD23-negative, FMC7-positive, with bright surface immunoglobulin and cyclin D1/SOX11 positivity. If markers are discordant, request t(11;14) testing rather than forcing a CLL diagnosis.
Calls a marked neutrophilia with a left shift chronic myeloid leukemia without checking the basophil count, leukocyte alkaline phosphatase score, or BCR-ABL, or dismisses CML because the WBC count is only modestly elevated.
Leukemoid reactions and CML overlap in morphology and WBC count, and the discriminating features are learned as isolated facts rather than a diagnostic pathway.
What to do instead
Check the basophil count and smear: toxic granulation and Döhle bodies favor a leukemoid reaction, while basophilia and a left-shifted myeloid sequence without dysplasia favor CML. Use the leukocyte alkaline phosphatase score (high in leukemoid reaction, low in CML) and confirm with BCR-ABL by FISH or PCR before assigning a diagnosis.
Interprets a mixing study as corrected whenever the aPTT falls into the reference range at any point, or as not corrected when it shortens substantially but remains slightly above the upper limit.
There is no single universal definition of correction, and partial shortening is easily misread under time pressure.
What to do instead
Apply a predefined operational rule: 50% correction at immediate mixing and after 2-hour incubation, with a Rosner index calculated when available. A factor deficiency corrects; an inhibitor typically does not. Remember time- and temperature-dependent factors such as factor VIII, and repeat the incubated mix before concluding an inhibitor is present.
Monitors unfractionated heparin therapy with the PT/INR and warfarin therapy with the aPTT, or uses the INR to titrate a heparin infusion.
The two tests are mentally grouped as 'coagulation monitoring' and are easily swapped when the underlying pathways are not actively recalled.
What to do instead
Anchor each drug to its test: unfractionated heparin is monitored with the aPTT or anti-Xa assay; warfarin is monitored with the PT/INR; low-molecular-weight heparin is monitored with anti-Xa when monitoring is indicated. Before interpreting any result, state which drug the patient is receiving and confirm the sample timing relative to the dose.
Releases a low platelet count from an impedance or optical analyzer without reviewing the smear and instrument flags, missing EDTA-induced platelet clumping or giant platelets.
Automated counts are trusted as final when the analyzer is functioning, and low-platelet flags are treated as nuisance alerts rather than preanalytical clues.
What to do instead
Review every low platelet result and flag by estimating platelets on the smear and looking for clumps, giant platelets, or platelet satellites. If EDTA-induced clumping is suspected, repeat the count in a citrate or heparin tube and apply the appropriate dilution correction; inspect the tube for clots before repeating.
Rejects a chemistry or hematology run on a single 1-2s control observation, or accepts a gradual shift because each individual point remains within 2 SD, ignoring 2-2s, 4-1s, and 10x rules.
The 1-2s rule is the first rule encountered and is misremembered as a rejection rule, while trend rules require reviewing the Levey-Jennings chart rather than the latest point.
What to do instead
Treat 1-2s as a warning only. Reject on 1-3s, 2-2s, R-4s, 4-1s, and 10x, and investigate shifts even when no single point exceeds 2 SD. Document the review, the rule triggered, and the corrective action before reporting patient results.